Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
NCT04551482Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2021
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Body Mass Index at 12 weeks. Started Jul 2021; status: recruiting.
02
Conditions
obesity
Beyond the preview
Go deeper on NCT04551482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04551482.